| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.0062 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |